LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1TAPI Technology & API Services
03 1ALP Pharm
04 1Catalent Pharma Solutions
05 1Cerbios-Pharma SA
06 1DISHMAN NETHERLANDS B.V.
07 1Formosa Laboratories
08 1Haoyuan Chemexpress Co.Ltd
09 1Lupin Ltd
10 1Polymed Therapeutics Inc.
11 1Sai Life Sciences Limited
12 1Sun Pharmaceutical Industries Limited
13 1Teva Pharmaceutical Industries
14 1Wuxi Fortune Pharmaceutical Co., Ltd
15 1Zhejiang Ausun Pharmaceutical
01 4China
02 3India
03 2Israel
04 1Netherlands
05 1Switzerland
06 1Taiwan
07 3U.S.A
01 7Active
02 3Inactive
03 5Blank
01 15Blank
01 15Blank
01 1WC-0130
02 1WC-0168
03 13Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
TAPI offers customized CDMO Solutions for API development and manufacturing services.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-11-04
Pay. Date : 2012-11-08
DMF Number : 15357
Submission : 2001-04-12
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-25
Pay. Date : 2014-03-10
DMF Number : 22120
Submission : 2008-10-27
Status : Active
Type : II
Date of Issue : 2022-07-26
Valid Till : 2025-07-14
Written Confirmation Number : WC-0130
Address of the Firm :
NDC Package Code : 14474-023
Start Marketing Date : 2012-10-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-09
Pay. Date : 2012-12-20
DMF Number : 22136
Submission : 2008-10-31
Status : Active
Type : II
NDC Package Code : 66499-0011
Start Marketing Date : 2006-06-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-06-01
Pay. Date : 2015-05-22
DMF Number : 25594
Submission : 2012-01-19
Status : Active
Type : II
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-11-08
Pay. Date : 2022-07-22
DMF Number : 37132
Submission : 2022-06-20
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-02-25
Pay. Date : 2014-07-29
DMF Number : 28353
Submission : 2014-07-03
Status : Active
Type : II
NDC Package Code : 54239-010
Start Marketing Date : 2014-06-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23233
Submission : 2010-04-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12838
Submission : 1998-01-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22590
Submission : 2009-03-05
Status : Inactive
Type : II
We have 15 companies offering Doxcercalciferol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
